admin

Since the late 1970s, when the former options trader and arbitrageur moved into activist investing (then called “corporate raiding”), Carl Icahn has built a multi-billion dollar fortune investing in (and pushing for profitable changes at) undervalued companies. With this track record, it’s no surprise that Wall Street and Main Street investors alike are always curious
0 Comments
With new innovation, high demand for better treatment, pharmaceutical companies strengthening pipelines and a resurgence of mergers and acquisitions, biotech stocks could offer some of the most explosive opportunities of the year. “What’s more, big pharmaceutical companies with sizable piles of cash and the need to address patent expirations on some top-selling products later this
0 Comments
With the stock market reaching new record highs, the list of stocks to sell grows. Driven in part by expectations around artificial intelligence (AI) developments, several companies have become significantly overextended relative to their underlying financial performance. While broader economic and monetary conditions support ongoing gains across indices, not all firms will be wise long-term
0 Comments
After witnessing some of the hottest software stocks skyrocket to dizzying valuations over the past few years, many investors wonder if opportunities remain in this high-flying sector. With sales multiples stretching well into the double digits for companies like Snowflake (NYSE:SNOW) and Datadog (NASDAQ:DDOG), I believe the easy money has already been made. Many of
0 Comments
The unpredictability of the biotech sector, highlights the inherent risks involved in certain biotech stocks to sell. 2023 was a rough year for the market, marked by a 10% plunge in the SPDR S&P Biotech ETF (XBI), alongside widespread layoffs and fundraising challenges. Moreover, despite forecasts pointing to a potential rebound in 2024, the biotech
0 Comments
Warren Buffett stocks always spark immense curiosity in the investing world. The Oracle of Omaha’s investment moves are closely watched, with his quarterly filings offering valuable insights. In the latest update, Berkshire Hathaway’s (NYSE:BRK.A,NYSE:BRK.B) 13F filing reveals a quiet fourth quarter marked by more selling than buying. Berkshire Hathaway, known for its wide-moat investment approach, reported
0 Comments
OpenAI’s recent introduction of Sora could provide the next step forward in leveraging artificial intelligence (AI) within the Metaverse. This will create an opportune moment for certain next-big-thing stocks. If generative AI technologies were a major focus of 2024, Apple’s (NASDAQ:AAPL) launch of its new Vision Pro product might help drive more widespread adoption of
0 Comments
Savvy investors are shifting their focus towards meme stocks to sell, adapting to the stock market’s changing trends where meme stocks have fallen out of favor. The trend, fueled by social media, morphed low-quality stocks into overnight sensations, spurring short-lived surges in value as online communities banded together. However, the excitement surrounding these stocks often
0 Comments